Thousands Sue Johnson & Johnson in UK Over Baby Powder Cancer Risk

Published: 16 October 2025 . The English Chronicle Desk

A major class-action lawsuit has been launched in the United Kingdom against the pharmaceutical and consumer goods giant Johnson & Johnson (J&J), accusing the company of knowingly selling asbestos-contaminated talcum powder for decades while concealing the health risks from the public. The claim, filed by over 3,000 people, could become the largest product liability case in British legal history.

According to court documents and internal company memos obtained by the BBC, J&J allegedly knew as early as the 1960s that its talc-based baby powder contained fibrous forms of minerals such as tremolite and actinolite—both of which, in their fibrous form, are classified as asbestos and have long been linked to deadly cancers, including mesothelioma and ovarian cancer. Despite this knowledge, the company is accused of continuing to market its baby powder as a symbol of purity, safety, and gentleness for mothers and infants worldwide.

The lawsuit, brought forward by KP Law, alleges that the company not only failed to warn consumers but also took active steps to suppress scientific evidence and manipulate safety standards. Instead of alerting regulators or the public, J&J allegedly focused on protecting its multibillion-dollar baby care brand, which became one of the company’s most iconic and profitable products.

Johnson & Johnson, however, has vehemently denied all allegations. In a statement, the firm maintained that its baby powder “was compliant with all applicable regulatory standards, did not contain asbestos, and does not cause cancer.” The company also pointed out that independent laboratories and global health authorities have repeatedly confirmed the safety of its talc products. Sales of talc-based baby powder were discontinued in the UK in 2023 and in the United States three years earlier.

The British case mirrors extensive litigation in the United States, where thousands of lawsuits have been filed over similar allegations. While some U.S. plaintiffs have won multimillion-dollar verdicts, others have seen those rulings overturned on appeal. Legal experts say the UK lawsuit could result in hundreds of millions of pounds in damages and reshape consumer safety law in the country.

Internal Evidence and Concealment Allegations

The claims against J&J centre on the long-debated link between talcum powder and cancer. Talc, a naturally occurring mineral used in cosmetics and hygiene products, is often mined near asbestos deposits. The fibrous form of asbestos, known for its needle-like structure, is a well-established cause of various cancers when inhaled or absorbed into the body.

Internal J&J documents cited in the lawsuit suggest that as early as 1973, the company was aware of the contamination issue. One memo reportedly stated: “Our baby powder contains talc fragments classifiable as fibres. Occasionally, sub-trace quantities of tremolite or actinolite are identifiable.” Rather than addressing the contamination, executives discussed ways to protect the brand image and even considered patenting a process to remove asbestos fibres from talc. However, they ultimately decided to keep the research confidential to avoid public scrutiny.

According to the claimants, J&J’s internal communications reveal a pattern of concealment stretching over decades. The company allegedly lobbied regulators, including the U.S. Food and Drug Administration (FDA), to adopt less sensitive testing methods that would fail to detect trace amounts of asbestos. The court filings allege that J&J advocated for standards that allowed up to one percent asbestos contamination, a threshold that would have permitted the company to maintain its claim of product purity.

Marketing Over Safety

While scientific evidence mounted, J&J’s marketing campaigns continued to portray its baby powder as the embodiment of softness, safety, and maternal care. During the 1970s and 1980s, U.S. advertisements targeted new mothers with slogans about purity and trust. By the 1990s and early 2000s, the company shifted its focus toward African American women, an expansion that critics now describe as a calculated effort to exploit underinformed consumers.

A 2008 internal email, obtained by the BBC, allegedly expressed concern about the product’s safety, reading: “The reality that talc is unsafe for use on or around babies is disturbing… I don’t think we can continue to call it baby powder and keep it in the baby aisle.” J&J later said the comment referred to asphyxiation risks from powder inhalation rather than asbestos-related cancers.

Voices of the Victims

Among the thousands of claimants is Siobhan Ryan, a 63-year-old mother from Somerset, who used Johnson & Johnson baby powder for decades, first as a child and later on her own children. “My mother used it, I used it, and it smelled lovely. I believed I was doing the best for my babies,” she told the BBC. In 2023, she was diagnosed with stage four ovarian cancer.

“It was such a shock. We just hugged and cried,” Ryan said. After enduring several rounds of chemotherapy, a severe case of sepsis, and major abdominal surgery, she is now undergoing further treatment as her cancer has returned. “They knew it was contaminated and still sold it to new mothers and babies,” she added.

Medical experts note that ovarian cancer can result from a combination of genetic and environmental factors. Professor Christina Fotopoulou, a leading gynaecological oncologist at Imperial College London, explained that “any external agent capable of disrupting the cell’s reproductive cycle can contribute to cancer development.”

Common symptoms of ovarian cancer include persistent abdominal bloating, pelvic pain, loss of appetite, and changes in urinary frequency. Doctors urge women experiencing such symptoms frequently to seek medical attention, as early diagnosis can dramatically improve survival rates.

Legal Fallout and Corporate Response

Earlier this month, a U.S. court in Connecticut ordered Johnson & Johnson and its successor entities to pay $25 million to a man who developed terminal mesothelioma after lifelong use of the company’s baby powder. The jury concluded that the company was negligent in continuing to sell asbestos-contaminated products despite knowing safer alternatives, such as cornstarch-based powders, were available.

Testimony from former J&J toxicologist Dr. Steve Mann revealed that company officials made public safety claims without reviewing laboratory test data. He admitted to receiving reports confirming asbestos in the powder but chose not to disclose them to regulators or management.

In recent years, Johnson & Johnson restructured its consumer health business under a new subsidiary named Kenvue, which now oversees its personal care brands. Kenvue issued a statement following the latest court rulings, saying: “We deeply sympathize with individuals and families affected by cancer. The safety of our products has been supported by decades of testing by independent laboratories, universities, and regulatory authorities worldwide.”

Despite repeated legal challenges, J&J maintains that its baby powder never contained asbestos and continues to insist that science supports its safety record. However, with thousands of lawsuits ongoing across multiple continents, the controversy surrounding the company’s iconic baby powder shows no sign of ending soon.

— The English Chronicle Online